News|Slideshows|June 10, 2026

7 Late-Breaking Clinical Trials to Watch For at SLEEP 2026

Fact checked by: Abigail Brooks, MA

Late-breaking SLEEP 2026 findings bring primary-care-ready insights on insomnia drugs, sleep apnea genetics, menopausal sleep, and GLP-1 links.

Sleep disorders touch virtually every corner of primary care, from the patient with treatment-resistant hypertension to the postmenopausal woman who hasn't slept through the night in years. Yet sleep medicine remains underrepresented in primary care training, and many clinically actionable findings from sleep research take years to reach the exam room.

The SLEEP 2026 annual meeting in Baltimore, Maryland, is bringing a slate of late-breaking abstracts with direct relevance to primary care practice. This year's presentations span insomnia pharmacology, obstructive sleep apnea genetics, menopausal sleep disturbances, and the rapidly evolving intersection of GLP-1 receptor agonists with sleep-disordered breathing.

The slideshow above highlights 7 late-breaking abstracts being presented this year that are most relevant to primary care clinicians.


Latest CME